US Patent Granted

US Patent No 11,026,692 ; Awarded to Elbe Valley Medical

8th June 2021

US Patent No 11,026,692 ; Device and System for Restricting Fluid Flow in Physiological Vessels was awarded to Elbe Valley Medical for devices and methods for embolizing tissue at the level of blood capillaries The purpose of this patent is to provide a roadmap for the treatment of all types of cancers (starting with large untreatable tumours and then working backwards to smaller ones). This patent roadmap contains three major components all invented by our founder Rob Reynolds.

We are delighted to have this breakthrough technology recognised as being novel and we look forward to progressing this therapy forward into the clinic as soon as possible.